Cover Image

Modified PEG-Lipids Enhance the Nasal Mucosal Immune Capacity of Lipid Nanoparticle mRNA Vaccines

Background/Objectives: Omicron, the predominant variant of SARS-CoV-2, exhibits strong immune-evasive properties, leading to the reduced efficacy of existing vaccines. Consequently, the development of versatile vaccines is imperative. Intranasal mRNA vaccines offer convenient administration and have...

Full description

Saved in:

Bibliographic Details
Main Authors:	Meng Li (Author), Jing Yi (Author), Yicheng Lu (Author), Ting Liu (Author), Haonan Xing (Author), Xiwei Wang (Author), Hui Zhang (Author), Nan Liu (Author), Zengming Wang (Author), Aiping Zheng (Author)
Format:	Book
Published:	MDPI AG, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles
by: Hiroki Tanaka, et al.
Published: (2021)

Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
by: Mae M. Lewis, et al.
Published: (2023)

Recent Advances in Lipid Nanoparticles for Delivery of mRNA
by: Lei Yang, et al.
Published: (2022)

Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method
by: Manon Berger, et al.
Published: (2023)

Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
by: Wei Wang, et al.
Published: (2022)

Lipid carriers for mRNA delivery
by: Wanting Zhang, et al.
Published: (2023)

Endocytic Uptake of Solid Lipid Nanoparticles by the Nasal Mucosa
by: Ammar S. Al Khafaji, et al.
Published: (2021)

In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
by: Cláudia Pina Costa, et al.
Published: (2021)

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
by: Kimberly J. Hassett, et al.
Published: (2019)

Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy
by: Christoph Wilhelmy, et al.
Published: (2023)

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
by: Magdalena M. Żak, et al.
Published: (2021)

Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
by: Christophe Delehedde, et al.
Published: (2021)

Development of a Library of Disulfide Bond-Containing Cationic Lipids for mRNA Delivery
by: Zhigao Shen, et al.
Published: (2023)

Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size
by: Ruimeng Shi, et al.
Published: (2024)

Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG-PCCL-modified magnetic iron oxide nanoparticles
by: Xinyi Li, et al.
Published: (2017)

Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics
by: Olga Vasileva, et al.
Published: (2024)

A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy
by: Masanori Sawamura, et al.
Published: (2024)

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
by: Sean C. Semple, et al.
Published: (2022)

Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells
by: Yoshiyuki Hattori, et al.
Published: (2019)

Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media
by: Lena Kliesch, et al.
Published: (2022)

PEG-Lipid-PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
by: Jana Ismail, et al.
Published: (2024)

PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency
by: Fei Yu, et al.
Published: (2017)

A review of technological developments in lipid nanoparticle application for mRNA vaccination
by: Tzu-Fu Yeh, et al.
Published: (2023)

Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
by: Adonis Sfera, et al.
Published: (2022)

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments
by: Hairui Zhang, et al.
Published: (2020)

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
by: Kosuke Sasaki, et al.
Published: (2022)

Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
by: Mena Hajiaghapour Asr, et al.
Published: (2023)

Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis
by: Masaki Gomi, et al.
Published: (2023)

PLA-PEG as an alternative to PEGylated lipids for nanoparticle-based DNA vaccination against SARS-CoV-2
by: Walison Nunes da Silva, et al.
Published: (2024)

Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency
by: Suhail Khoja, et al.
Published: (2022)

Drug-loaded PEG-PLGA nanoparticles for cancer treatment
by: Dan Zhang, et al.
Published: (2022)

Identification of film-based formulations that move mRNA lipid nanoparticles out of the freezer
by: Trang Nguyen Kieu Doan, et al.
Published: (2024)

Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
by: Xuan Du, et al.
Published: (2023)

Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid-polymer hybrid nanoparticles, which performed better for local anesthetic therapy?
by: Min Li, et al.
Published: (2020)

Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid-polymer hybrid nanoparticles
by: Qingxia Fu, et al.
Published: (2020)

Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
by: Edo Kon, et al.
Published: (2020)

Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy
by: Rocío Gambaro, et al.
Published: (2024)

mRNA-Loaded Lipid Nanoparticles Targeting Immune Cells in the Spleen for Use as Cancer Vaccines
by: Ryoya Shimosakai, et al.
Published: (2022)

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
by: Duan W, et al.
Published: (2018)

Alterations of Autophagy Modify Lipids in Epidermal Keratinocytes
by: Geng Q, et al.
Published: (2023)